• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCEVE
Ceres Ventures Inc
8.6K
0.0x
---
United StatesMZPS
American Environmental Inc
50.0
0.0x
---
United StatesCDVM
Carson Energy Development Corp
190.0
0.0x
---
United StatesXREG
XR Energy Inc
200.0
0.0x
---
United StatesGSLO
Go Solar USA Inc
650.0
0.0x
---
United StatesAMSU
Amanasu Environment Corp
40.0
0.0x
---
As of 2024-04-28

Company Information

Ceres Ventures, Inc., formerly PhytoMedical Technologies, Inc., together with its wholly owned subsidiaries, BluFlow Technologies, Inc. (BluFlow) and Nascent Water Technologies, Inc. (Nascent) is focused on the research, development, and eventual commercialization of emerging next-generation clean technologies for the remediation of polluted water, soil, and air. The Company's product offerings include BluFlow Treatment System, The BluFlow Nanoparticles Advantage, and Benefits of the BluFlow AUT. On December 29, 2011, Ceres Ventures, Inc. completed a reverse merger with BluFlowTM Technologies, Inc. and BluFlowTM Technologies, Inc. became a wholly owned subsidiary of Ceres Ventures, Inc. The Company changed its name to Ceres Ventures, Inc. on November 21, 2011.

Contact Information

Headquarters
430 Park AveNEW YORK, NY, United States 10022-3505
Phone
800-611-3388
Fax
561-694-1639

Executives

Interim Chief Executive Officer
Amu Fowler
Interim Chief Financial Officer
Frank Fabio
Director
Meetesh Patel
Director
Joseph Sierchio

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$8.6K
Revenue (TTM)
$0.00
Shares Outstanding
85.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.01
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.